November 18, 2026
Health news, explained with evidence
LIVE

Study Examines Impact of Blood Sugar and Cholesterol Levels on Diabetic Neuropathy Risk

❤️ Conditions & Care 2 min read 👁 3

Recent research published in Nature Health Sciences evaluates how glycated haemoglobin and low-density lipoprotein cholesterol levels influence the likelihood of type 2 diabetic neuropathy.

❤️Conditions & Care

Key points

  • HbA1c levels of 7% and above were significantly linked to a higher risk of type 2 diabetic neuropathy.
  • Low-density lipoprotein cholesterol alone did not show a direct association with neuropathy risk in this cohort.
  • The combination of elevated cholesterol and severe hyperglycemia markedly compounded the risk of nerve complications.

A new investigation led by researchers from the Second Affiliated Hospital of Harbin Medical University has explored the joint association of glycated haemoglobin, commonly known as HbA1c, and low-density lipoprotein cholesterol with the onset of type 2 diabetic neuropathy. Drawing upon data from the UK Biobank involving 1,484 participants followed over a 12-year period, alongside a separate clinical analysis of 611 patients, the study assessed how metabolic markers affect neurological complications in diabetes.

The findings indicate that elevated HbA1c levels independently heighten the risk of developing diabetic neuropathy. Specifically, compared to individuals maintaining an HbA1c below 7%, those with readings between 7% and 9% faced a significantly higher hazard ratio of 1.62, while patients with levels at or exceeding 9% experienced an increased hazard ratio of 2.44. Conversely, low-density lipoprotein cholesterol levels at or above 2.6 mmol/L were not found to independently increase neuropathy risk. However, when high cholesterol coexisted with very poor blood sugar control at or above 9% HbA1c, the risk escalated further to a hazard ratio of 2.80.

What to know: While the research points to blood sugar management as a critical factor in mitigating neuropathy risks, readers should talk to a doctor for personal medical decisions and tailored treatment plans. The study relies on observational data and statistical modeling, meaning it establishes associations rather than direct cause-and-effect outcomes.

"HbA1c is an independent risk factor for neuropathy in patients with T2DM. LDL-C is not associated with type 2 diabetic neuropathy. However, in the context of suboptimal LDL-C control, extremely poor HbA1c control is closely associated with diabetic neuropathy than well controlled HbA1c."

Co-authored by researchers including Na Lv and Shengnan Gao, the paper highlights the complex interplay of metabolic factors in chronic disease management. Future clinical approaches may benefit from addressing combined lipid and glycemic parameters, though further clinical trials are necessary to confirm these patterns across broader populations.

Source Nature Health Sciences — nature.com/articles/s41598-026-80710-y ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.